| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 150.16B | 154.90B | 145.20B | 138.46B | 131.24B | 110.95B |
| Gross Profit | 42.95B | 49.67B | 41.10B | 39.16B | 35.09B | 34.08B |
| EBITDA | 19.62B | 23.93B | 16.23B | 17.48B | 13.97B | 16.21B |
| Net Income | 10.28B | 16.64B | 8.41B | 7.99B | 6.95B | 11.69B |
Balance Sheet | ||||||
| Total Assets | 237.33B | 240.41B | 225.83B | 225.05B | 201.91B | 185.76B |
| Cash, Cash Equivalents and Short-Term Investments | 30.69B | 29.42B | 24.95B | 19.98B | 17.66B | 27.07B |
| Total Debt | 65.59B | 70.73B | 68.94B | 68.06B | 52.92B | 46.83B |
| Total Liabilities | 121.73B | 111.22B | 111.38B | 118.93B | 104.48B | 93.89B |
| Stockholders Equity | 115.41B | 128.99B | 114.27B | 106.07B | 97.43B | 91.87B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.49B | 8.53B | -10.35B | -10.64B | 12.02B |
| Operating Cash Flow | 0.00 | 17.26B | 18.33B | -2.81B | -6.02B | 16.50B |
| Investing Cash Flow | 0.00 | -10.01B | -11.41B | -7.04B | -5.02B | -4.32B |
| Financing Cash Flow | 0.00 | -3.82B | -2.34B | 11.52B | 1.05B | -11.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥107.35B | 9.69 | ― | 3.72% | 4.49% | 27.96% | |
76 Outperform | ¥118.43B | 6.82 | ― | 4.15% | 6.68% | 97.70% | |
73 Outperform | ¥74.42B | 8.66 | ― | 3.04% | -0.37% | -20.95% | |
69 Neutral | ¥2.34T | 12.03 | 11.64% | 1.52% | 11.97% | 45.59% | |
64 Neutral | ¥456.05B | 10.04 | 8.14% | 2.61% | -0.45% | 50.53% | |
63 Neutral | ¥416.58B | 13.72 | 13.71% | 3.38% | 0.16% | -12.55% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |